Heo JH, Lucero J, Abumiya T, et al. Matrix metalloproteinases
increase very early during experimental focal cerebral ischemia.
J Cereb Blood Flow Metab 1999;19:624 – 633.
Gasche Y, Copin JC, Sugawara T, et al. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain
barrier disruption after transient focal cerebral ischemia. J Cereb
Blood Flow Metab 2001;21:1393–1400.
Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain
barrier disruption in mice after focal cerebral ischemia and
reperfusion. Brain Res 1999;842:92–100.
Rosenberg GA, Navratil M. Metalloproteinase inhibition blocks
edema in intracerebral hemorrhage in the rat. Neurology 1997;
48:921–926.
Lapchak PA, Chapman DF, Zivin JA. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)induced hemorrhage after thromboembolic stroke. Stroke 2000;
31:3034 –3040.
Yrjanheikki J, Keinanen R, Pellikka M, et al. Tetracyclines in-hibit microglial activation and are neuroprotective in global
brain ischemia. Proc Natl Acad Sci USA 1998;95:
15769 –15774.
Brundula V, Rewcastle NB, Metz L, et al. Targeting leukocyte
MMPs and transmigration: minocycline as a novel therapeutic
for multiple sclerosis. Brain 2002;125:1297–1308.
Oh LY, Larsen PH, Krekoski CA, et al. Matrix
metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 1999;19:8464 – 8475.
Power C, Kong PA, Crawford TO, et al. Cerebral white matter
changes in acquired immunodeficiency syndrome dementia: al-terations of the blood-brain barrier. Ann Neurol 1993;34:
339 –350.
Imai Y, Ibata I, Ito D, et al. A novel gene iba1 in the major
histocompatibility complex class III region encoding an EF
hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996;224:855– 862.
Johnston JB, Silva C, Gonzalez G, et al. Diminished adenosine A1 receptor expression on macrophages in brain and
blood of patients with multiple sclerosis. Ann Neurol 2001;
49:650 – 658.
Colbourne F, Corbett D. Delayed postischemic hypothermia:
a six month survival study using behavioral and histological
assessments of neuroprotection. J Neurosci 1995;15:
7250 –7260.
Rosenberg GA, Kornfeld M, Estrada E, et al. TIMP-2 reduces
proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 1992;576:203–207.
Wu L, Fan J, Matsumoto S, Watanabe T. Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40
signaling in monocyte/macrophages. Biochem Biophys Res
Commun 2000;269:808 – 815.
Hummel V, Kallmann BA, Wagner S, et al. Production of
MMPs in human cerebral endothelial cells and their role in
shedding adhesion molecules. J Neuropathol Exp Neurol 2001;
60:320 –327.
Beliveau R, Delbecchi L, Beaulieu E, et al. Expression of matrix
metalloproteinases and their inhibitors in human brain tumors.
Ann N Y Acad Sci 1999;886:236 –239.
Wu L, Fan J, Matsumoto S, Watanabe T. Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40
signaling in monocyte/macrophages. Biochem Biophys Res
Commun 2000;269:808 – 815.
Xue M, Del Bigio MR. Acute tissue damage after injections of
thrombin and plasmin into rat striatum. Stroke 2001;32:
2164 –2169.
